← back to search

Terho Heikkinen

University of Turku · FI
🔎 Find collaborators in Epidemiology · Otorhinolaryngology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Epidemiology · Otorhinolaryngology
Research interest
Research interests include Respiratory viral infections research, Pneumonia and Respiratory Infections, Influenza Virus Research Studies, and Ear Surgery and Otitis Media.
h-index
66
citations
16,815
works
245
NIH funding
primary concept
Medicine
email

Recent publications

Comparison of Hospitalization Rates and Clinical Features Between Boys and Girls With Respiratory Syncytial Virus Infection.
2026cited by 1position: contributordoi
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic.
2025cited by 38position: contributordoi
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling study
The Lancet Regional Health - Europe 2025cited by 13position: middledoi
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children
Expert Review of Anti-infective Therapy 2025cited by 12position: middledoi
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling study.
2025cited by 11position: contributordoi
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants
Nature Communications 2025cited by 10position: middledoi
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants.
2025cited by 8position: contributordoi
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.
2025cited by 7position: contributordoi
Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre- and post-COVID-19 pandemic.
2025cited by 4position: contributordoi
Antibiotic use attributable to RSV infections during infancy-an international prospective birth cohort study.
2025cited by 2position: contributordoi
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce.
2025cited by 2position: contributordoi
Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023.
2025cited by 1position: contributordoi
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data
The Lancet 2024cited by 168position: middledoi
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
2024cited by 116position: contributordoi
Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis.
2024cited by 82position: contributordoi
Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.
2024cited by 41position: contributordoi
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus
Nature Communications 2024cited by 24position: middledoi
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus.
2024cited by 21position: contributordoi
Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study.
2024cited by 12position: contributordoi
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.
2024cited by 8position: contributordoi
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study.
2024cited by 6position: contributordoi
Respiratory Syncytial Virus-Associated Hospitalizations in Children: A 10-Year Population-Based Analysis in Finland, 2008-2018.
2024cited by 5position: contributordoi
Inconsistent Increase in Age at Respiratory Syncytial Virus Hospitalization of Children Aged <2 Years During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Retrospective Multicenter Study in 4 European Countries.
2024cited by 4position: contributordoi
Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study.
2024cited by 4position: contributordoi
Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.
2024cited by 3position: contributordoi
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.
2023cited by 294position: contributordoi
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.
2023cited by 173position: contributordoi
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
The Lancet Infectious Diseases 2023cited by 101position: middledoi
Estimation of the Number of Respiratory Syncytial Virus–Associated Hospitalizations in Adults in the European Union
The Journal of Infectious Diseases 2023cited by 99position: middledoi
Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years.
2023cited by 80position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Thea Kølsen Fischer · Universitetshospitalernes Center for Sundhedsfaglig Forskning31 papers (2019–2025)Harish Nair · University of Edinburgh24 papers (2015–2025)Federico Martinón-Torres · Hospital General Universitario Gregorio Marañón23 papers (2019–2024)Harry Campbell · Nanjing Medical University20 papers (2019–2024) · 15 papers (2020–2025)Carlo Giaquinto · University of Padua12 papers (2020–2024)You Li · University of Science and Technology Beijing12 papers (2019–2025)Steve Cunningham · Royal Hospital for Children12 papers (2020–2025)Xin Wang · Kyushu University11 papers (2019–2025) · 10 papers (2021–2025)Ting Shi · Guiyang University8 papers (2020–2022)Simon B. Drysdale · St George’s University Hospitals NHS Foundation Trust8 papers (2020–2024)Rafael Mikolajczyk · University Hospital Magdeburg8 papers (2020–2020)Marta C. Nunes · Institut thématique Santé Publique7 papers (2018–2024) · 6 papers (2020–2025)Maarten Van den Berge · Ghent University Hospital6 papers (2019–2020)Jeroen Aerssens · Hasselt University5 papers (2020–2024)Javier Díez‐Domingo · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana5 papers (2020–2024)Anne Greenough · King's College London5 papers (2015–2023)Eugenio Baraldi · Veneto Institute of Molecular Medicine4 papers (2015–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Epidemiology · Otorhinolaryngology →